Saturday, October 07, 2017 10:50:05 AM
the 2 Corporate Clinics in Ohio - Parma and Sandusky.
How is PAOG going to exit from the last PR?
1. Two Corporate Clinics - Toledo and Dayton, Ohio -
open and accepting appointments in the first part
of October.
2. Jacksonville, Florida Corporate Clinic open and
accepting appointments in November with the
St Augustine, Florida Clinic soon to follow.
3. Company is working with an Attorney who represents
a Physicians Group in the state of Pennsylvania with
plans to replicate the corporate location models set forth
in Ohio and Florida.
4. Company is in discussions with a physician
in Arkansas to establish a corporate location there,
5. Arthur Hall and VP of Operations, Chris Will
have scouted the state of Michigan and look to
create near-term opportunity for PAO group with
multiple locations there.
If the above is a Scam PR it sure is an elaborate
one and will not be easy to exit from.
"He continues, "Despite the conditions here, we are
confident that our Jacksonville, Florida location will
be open and taking appointments in November and
we have finalized permits in St. Augustine for our
corporate location there, with an opening soon to follow.
We are very pleased with progress on all fronts and
are well positioned for further expansion."
"Construction on the Company's Toledo and Dayton, Ohio
corporate locations is complete and we are currently
outfitting and staffing those locations. We will be accepting
appointments in both locations in the first part of October."
Director of Operations, Arthur Hall and VP of Operations,
Chris Will have scouted the state of Michigan and look
to create near-term opportunity for PAO group with
multiple locations there. As well, the company is working
with an attorney that represents a Physicians Group in
the state of Pennsylvania with plans to replicate the
corporate location models set forth in Ohio and Florida.
"We are also in discussions with a physician in Arkansas
to establish a corporate location there," adds Weber. "
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM